Aurinia Pharmaceuticals Inc. buy BiotechBee
Start price
04.01.23
/
60%
€6.46
Target price
31.12.25
€12.00
Performance (%)
63.49%
End price
05.05.23
€10.56
Summary
This prediction ended on 05.05.23 with a price of €10.56. The BUY prediction by BiotechBee for Aurinia Pharmaceuticals Inc. saw massive gains of 63.49%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 0.444% | 0.444% | 88.875% | 45.704% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % | 48,43 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % | 84,28 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % | 59,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % | 62,51 % |
According to BiotechBee what are the pros and cons of Aurinia Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aurinia Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 12,0
In the thread Trading Aurinia Pharmaceuticals Inc.
Buy beendet

